Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Science and Society
  • Published:

Rheumatology in India—quo vadis?

Nature Reviews Rheumatology volume 11, pages 183–188 (2015)Cite this article

Subjects

Abstract

Rheumatology has been a neglected subspecialty in India. A staggering patient load, a severely inadequate number of trained rheumatology specialists, therapeutic nihilism and limited advocacy are some of the critical challenges that confront rheumatology care, and possibly explain the high rates of reliance on complementary and alternative medicines in India. Disease spectrum and treatment patterns are not remarkably different from those in other countries, but biologic agents have limited use and are administered for short periods only. Consequently, outcomes in India do not yet match those reported in developed countries. Furthermore, the high prevalence of infectious diseases continues to be a major contributor to mortality in patients with rheumatic disorders such as systemic lupus erythematosus. Several tropical diseases with rheumatic manifestations are relevant in India, including chikungunya, brucellosis, leptospirosis, dengue and melioidosis. To address the many problems with rheumatology care in India, curricular reforms, capacity building, patient education and political support are sorely needed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Challenges to rheumatology in India and possible solutions.

References

  1. Ministry of Health and Family Welfare, Government of India. Census 2001 and 2011—Key indicators [online], (2014).

  2. World Health Organization. Global Health Observatory Data Repository. Life expectancy data by country [online], (2012).

  3. WHO–Ministry of Health and Family Welfare, Government of India. National action plan and monitoring framework for prevention and control of noncommunicable diseases (NCDs) in India. WHO–Government of India 2012–2013 Biennial Workplan [online], (2014).

  4. Chopra, A. COPCORD—An unrecognized fountainhead of community rheumatology in developing countries. J. Rheumatol. 31, 2320–2323 (2004).

    PubMed  Google Scholar 

  5. Chopra, A., Patil, J., Billempelly, V., Relwani, J. & Tandle, H. S. Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD study. J. Assoc. Physicians India 49, 240–246 (2001).

    CAS  PubMed  Google Scholar 

  6. Joshi, V. L. & Chopra, A. Is there an urban-rural divide? Population surveys of rheumatic musculoskeletal disorders in the Pune region of India using the COPCORD Bhigwan model. J. Rheumatol 36, 614–622 (2009).

    Article  Google Scholar 

  7. Malaviya, A. N., Kapoor, S. K., Singh, R. R., Kumar, A. & Pande, I. Prevalence of rheumatoid arthritis in the adult Indian population. Rheumatol. Int. 13, 131–134 (1993).

    Article  CAS  Google Scholar 

  8. Central Intelligence Agency. The World Factbook. https://www.cia.gov/library/publications/the-world-factbook/fields/2010.html (2014).

  9. Lagu-Joshi, V., Chanchani, E., Saluja, M., Anuradha, V. & Chopra, A. Prevalence of rheumatic musculoskeletal disorders (RMSK) in a West Indian urban population: a bone and joint decade (BJD) India 'Burden of Disease Project'. American College of Rheumatology [online] (2007).

    Google Scholar 

  10. Chopra, A. & Abdel-Nasser. A. Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract. Res. Clin. Rheumatol. 22, 583–604 (2008).

    Article  Google Scholar 

  11. Malaviya, A. N., Singh. R. R., Singh, Y. N., Kapoor, S. K. & Kumar, A. Prevalence of systemic lupus erythematosus in India. Lupus 2, 115–118 (1993).

    Article  CAS  Google Scholar 

  12. Malaviya, A. N. et al. Indian Rheumatology Association consensus statement on the diagnosis and treatment of axial spondyloarthropathies. Ind. J. Rheumatol. 5, 16–34 (2010).

    Article  Google Scholar 

  13. Dey, A. B. & Handa, R. Action Plan Osteoporosis. (Osteoporosis Society of India, New Delhi, 2003).

    Google Scholar 

  14. Handa, R., Kalla, A. A. & Maalouf, G. Osteoporosis in developing countries. Best Pract. Res. Clin. Rheumatol. 22, 693–708 (2008).

    Article  Google Scholar 

  15. Malaviya, A. N. et al. Clinical and immunogenetic studies in rheumatoid arthritis from northern India. Rheumatol. Int. 3, 105–108 (1983).

    Article  CAS  Google Scholar 

  16. Aggarwal, R. & Malaviya, A. N. Clinical characteristics of patients with ankylosing spondylitis in India. Clin. Rheumatol. 28, 1199–1205 (2009).

    Article  Google Scholar 

  17. Sobti, P. & Bhasin, R. C. Gout in India. (A study of clinical features). J. Assoc. Physicians India 16, 961–965 (1968).

    CAS  PubMed  Google Scholar 

  18. Malaviya, A. N., Chandrasekaran, A. N., Kumar, A. & Shamar, P. N. Systemic lupus erythematosus in India. Lupus 6, 690–700 (1997).

    Article  CAS  Google Scholar 

  19. Aggarwal, R. & Malaviya, A. N. Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes—an Indian perspective. Clin. Rheumatol. 28, 327–331 (2009).

    Article  Google Scholar 

  20. Handa, R., Wali, J. P., Biswas, A., Aggarwal, P. & Wig, N. Wegener's granulomatosis- A clinicopathologic study. J. Assoc. Physicians India 45, 536–539 (1997).

    Google Scholar 

  21. Handa, R., Farooqi, A. Z., Haq, S. A. & Wali, J. P. Wegener's granulomatosis in the Indian Subcontinent. APLAR J. Rheumatol. 2, 210–215 (1999).

    Google Scholar 

  22. Hadda, V. et al. Disease activity and lipids in rheumatoid arthritis: a prospective study. Ind. J. Rheumatol. 2, 137–140 (2007).

    Article  Google Scholar 

  23. Mahajan, V. et al. Assessment of atherosclerosis by carotid intimomedial thickness in patients with rheumatoid arthritis. J. Assoc. Physicians India 56, 587–590 (2008).

    CAS  PubMed  Google Scholar 

  24. Grover, S. et al. Subclinical atherosclerosis in rheumatoid arthritis in India. J. Rheumatol. 33, 244–247 (2006).

    PubMed  Google Scholar 

  25. Bhatt, S. P. et al. Atherosclerosis in Asian Indians with systemic lupus erythematosus. Scand. J. Rheumatol. 35, 128–132 (2006).

    Article  CAS  Google Scholar 

  26. Ghosh, P. et al. Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus. Clin. Rheumatol. 28, 1259–1265 (2009).

    Article  Google Scholar 

  27. Shankar, S. et al. Bone mineral density in Indian women with rheumatoid arthritis. Rheumatol. Int. 29, 377–381 (2009).

    Article  Google Scholar 

  28. Gokhale, Y. A., Bichile, L. S., Gogate, A., Tillu, A. V. & Zamre . Brucella spondylitis: an important treatable cause of low backache. J. Assoc. Physicians India 47, 384–388 (1999).

    Google Scholar 

  29. Kochar, D. K. et al. Hospital-based case series of 175 cases of serologically confirmed brucellosis in Bikaner. J. Assoc. Physicians India 55, 271–275 (2007).

    CAS  PubMed  Google Scholar 

  30. Chopra, A., Anuradha, V., Ghorpade, R. & Saluja, M. Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol. Infect. 140, 842–850 (2012).

    Article  CAS  Google Scholar 

  31. Taraphdar, D., Sarkar, A., Mukhopadhyay, B. B., Chakrabarti, S. & Chatterjee, S. Rapid spread of chikungunya virus following its resurgence during 2006 in West Bengal, India. Trans. R. Soc. Trop. Med. Hyg. 106, 160–166 (2012).

    Article  Google Scholar 

  32. Mathew, A. J. et al. Rheumatic-musculoskeletal pain and disorders in a naïve group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study. Int. J. Clin. Pract. 65, 1306–1312 (2011).

    Article  CAS  Google Scholar 

  33. Chopra, A., Saluja, M. & Venugopalan, A. Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol. 66, 319–326 (2014).

    Article  CAS  Google Scholar 

  34. Sethi S. et al. Increasing trends of leptospirosis in Northern India: a clinico-epidemiological study. PLoS Negl. Trop. Dis. 4, e579 (2010).

    Article  Google Scholar 

  35. Adebajo, A. O. Dengue arthritis. Br. J. Rheumatol. 35, 909–910 (1996).

    Article  CAS  Google Scholar 

  36. Talib, S., Bhattu, S., Bhattu, R., Deshpande, S. & Dahiphale, D. Dengue fever triggering systemic lupus erythematosus and lupus nephritis: a case report. Int. Med. Case Rep. J. 6, 71–75 (2013).

    Article  Google Scholar 

  37. Rajadhyaksha, A. & Mehra, S. Dengue fever evolving into systemic lupus erythematosus and lupus nephritis: a case report. Lupus 21, 999–1002 (2012).

    Article  CAS  Google Scholar 

  38. Handa, R., Wali, J. P., Singh, S. & Aggarwal, P. A prospective study of Lyme arthritis in north India. Ind. J. Med. Res. 110, 107–109 (1999).

    CAS  Google Scholar 

  39. Shyam, C. & Malaviya, A. N. Infection-related morbidity in systemic lupus erythematosus: a clinico-epidemiological study from northern India. Rheumatol. Int. 16, 1–3 (1996).

    Article  CAS  Google Scholar 

  40. Dhir, V., Aggarwal, A., Lawrence, A., Agarwal, V. & Misra, R. Long-term outcome of lupus nephritis in Asian Indians. Arthritis Care Res. (Hoboken) 64, 713–720 (2012).

    Article  Google Scholar 

  41. Bedi, G. S., Gupta, N., Handa, R., Pal, H. & Pandey, R. M. Quality of life in Indian patients with rheumatoid arthritis. Qual. Life Res. 14, 1953–1958 (2005).

    Article  Google Scholar 

  42. Khanna, S., Pal, H., Pandey, R. M. & Handa, R. The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology (Oxford) 43, 1536–1540 (2004).

    Article  CAS  Google Scholar 

  43. Haroon, N., Aggarwal, A., Lawrence, A., Agarwal, V. & Misra, R. Impact of rheumatoid arthritis on quality of life. Mod. Rheumatol. 17, 290–295 (2007).

    Article  Google Scholar 

  44. Kumar, A. Indian Guidelines on the management of SLE. J. Indian Rheumatol. Assoc. 10, 80–96 (2002).

    Google Scholar 

  45. Misra, R. et al. Indian Rheumatology Association consensus statement on the management of adults with rheumatoid arthritis. Indian J. Rheumatol. 3 (Suppl.), S1–S16 (2008).

    Article  Google Scholar 

  46. Venkataraman, K. et al. Indian Rheumatology Association guidelines for management of glucocorticoid-induced osteoporosis. Endorsed by: Endocrine Society of India and Indian Society for Bone & Mineral Research. Indian J. Rheumatol. 6, 68–75 (2011).

    Article  Google Scholar 

  47. Agarwal, S., Zaman, T. & Handa, R. Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Singapore Med. J. 50, 686–692 (2009).

    CAS  PubMed  Google Scholar 

  48. Kumar, A. Experience with anti-tumor necrosis factor-α therapy in India. APLAR J. Rheumatol. 9, 136–141 (2006).

    Article  Google Scholar 

  49. Chaturvedi, V. P. & Singal, V. K. (2004). No case of tuberculosis with low dose infliximab without loading dose in ankylosing spondylitis—retrospective analysis of 108 cases. Presented at the 11th Asia Pacific League of Associations for Rheumatology (APLAR) Congress 2004.

  50. Handa, R. et al. Guidelines for tuberculosis prophylaxis during anti-tumour necrosis factor-α treatment: Indian Rheumatology Association. APLAR J. Rheumatol. 9, 181–183 (2006).

    Article  Google Scholar 

  51. Indian Rheumatology Association. Indian Rheumatology Association Biologics Registry [online] (2010).

  52. Aggarwal, A. & Sawhney, S. From the Editor's desk. Ind. J. Rheumatol. 7 (Suppl.), iv (2012).

    Article  Google Scholar 

  53. Aggarwal, A., Agarwal, V., Danda, D. & Misra, R. Outcome in juvenile rheumatoid arthritis in India. Indian Pediatr. 41, 180–184 (2004).

    PubMed  Google Scholar 

  54. Sawhney, S. Spectrum of juvenile idiopathic arthritis in a tertiary care centre in northern India. Ind. J. Rheumatol. 14, 3–6 (2006).

    Google Scholar 

  55. Singh, S. et al. Clinico-immunological profile of juvenile rheumatoid arthritis at Chandigarh. Indian Pediatr. 36, 449–454 (1999).

    CAS  PubMed  Google Scholar 

  56. Chandrasekaran, A. N., Rajendran, C. P. & Madhavan, R. Juvenile rheumatoid arthritis—Madras experience. Indian J. Pediatr. 63, 501–510 (1996).

    Article  CAS  Google Scholar 

  57. Aggarwal, A. & Misra, R. N. Juvenile rheumatoid arthritis in India—rarity of antinuclear antibody and uveitis. Indian J. Pediatr. 63, 301–304 (1996).

    Article  CAS  Google Scholar 

  58. Sawhney, S. & Manners, P. The place of pediatric rheumatology in India. Ind. J. Pediatr. 77, 993–996 (2010).

    Article  Google Scholar 

  59. Kumar, A. et al. Survival in patients with systemic lupus erythematosus in India. Rheumatol. Int. 12, 107–109 (1992).

    Article  CAS  Google Scholar 

  60. Murali, R. et al. Systemic lupus erythematosus in Indian patients: Prognosis, survival and life expectancy. Natl Med. J. India 10, 159–164 (1997).

    CAS  PubMed  Google Scholar 

  61. Sharma, A. et al. Causes of mortality among in patients with systemic lupus erythematosus in a tertiary care hospital in North India over a 10-year period. Lupus 22, 216–222 (2013).

    Article  CAS  Google Scholar 

  62. Gupta, A., Agarwal, A. & Handa, R. Pregnancy in Indian patients with systemic lupus erythematosus. Lupus 14, 926–927 (2005).

    Article  CAS  Google Scholar 

  63. Aggarwal, A., Chandran, S. & Misra, R. Physical, psychosocial and economic impact of rheumatoid arthritis: a pilot study of patients seen at a tertiary care referral centre. Natl Med. J. India 19, 187–191 (2006).

    PubMed  Google Scholar 

  64. Zaman, T., Agarwal, S. & Handa, R. Complementary and alternative medicine use in rheumatoid arthritis- An audit of patients visiting a tertiary care centre. Natl Med. J. India 20, 236–239 (2007).

    PubMed  Google Scholar 

  65. Rao, P. & Prasanna, N. M. Immunological studies on rheumatoid arthritis treated with homeopathic drugs: results of the pilot study. Ind. J. Res. Homoeopathy 2, 42–49 (2008).

    Google Scholar 

  66. Chopra, A. Ayurvedic medicine and arthritis. Rheum. Dis. Clin. North Am. 26, 133–144 (2000).

    Article  CAS  Google Scholar 

  67. Chopra, A. & Doiphode, V. V. Ayurvedic medicine. Core concept, therapeutic principles, and current relevance. Med. Clin. North Am. 86, 75–89 (2002).

    Article  Google Scholar 

  68. Basnyat, S. & Kolasinski, S. L. Ayurvedic medicine for rheumatoid arthritis. Curr. Rheumatol. Rep. 16, 435 (2014).

    Article  Google Scholar 

  69. Chopra, A. et al Randomized controlled exploratory evaluation of standardized ayurvedic formulations in symptomatic osteoarthritis knees: a government of India NMITLI project. Evid. Based Complement. Alternat. Med. 2011, 724291 (2011).

    Article  Google Scholar 

  70. Chopra, A. et al. Comparable efficacy of standardized Ayurveda formulation and hydroxychloroquinesulfate (HCQS) in the treatment of rheumatoid arthritis (RA): a randomized investigator-blind controlled study. Clin. Rheumatol. 31, 259–269 (2012).

    Article  Google Scholar 

  71. Chopra, A. et al. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology (Oxford) 52, 1408–1417 (2013).

    Article  CAS  Google Scholar 

  72. Handa R. Rheumatology in postgraduate curriculum. Indian J. Rheumatol. 9, 127–130 (2014).

    Article  Google Scholar 

Download references

Acknowledgements

The opinions expressed in this article are mine, and do not necessarily reflect the views of the Indian Rheumatology Association, the Asia–Pacific League of Associations for Rheumatology (APLAR), the International League of Associations for Rheumatology (ILAR) or the Indian government.

Author information

Authors and Affiliations

  1. Indraprastha Apollo Hospitals, Sarita Vihar, New Delhi, 110076, India

    Rohini Handa

Authors
  1. Rohini Handa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rohini Handa.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Handa, R. Rheumatology in India—quo vadis?. Nat Rev Rheumatol 11, 183–188 (2015). https://doi.org/10.1038/nrrheum.2014.182

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2014.182

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing